Conning Inc’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-347
Closed -$553K 579
2018
Q1
$553K Buy
347
+7
+2% +$11.2K 0.02% 373
2017
Q4
$305K Buy
+340
New +$305K 0.01% 498